Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study.
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To date, liver biopsy has been the gold standard used to differentiate between simple steatosis and steatohepatitis/fibrosis. Our aim was to compare the relevance of serum non-invasive parameters and scor...
Main Authors: | Karel Dvorak, Jan Stritesky, Jaromir Petrtyl, Libor Vitek, Renata Sroubkova, Martin Lenicek, Vaclav Smid, Martin Haluzik, Radan Bruha |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4211730?pdf=render |
Similar Items
-
Osteopontin – A potential biomarker of advanced liver disease
by: Radan Bruha, et al.
Published: (2020-07-01) -
The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic
by: Karel Dvorak, et al.
Published: (2015-09-01) -
No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C(♦)(♦)This work was supported by a grant No. NR9412-3/2007 given by the Czech Ministry of Health.
by: Petr Urbánek, et al.
Published: (2011-10-01) -
Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children
by: Kattayoun Kordy, et al.
Published: (2021-08-01) -
Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand
by: Pochamana Phisalprapa, et al.
Published: (2021-03-01)